Home
GW Pharmaceuticals

GW Pharmaceuticals Market Share Analysis for June 2026

jazz pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.

Health > Biotechnology and Pharmaceuticals

Domaingwpharm.com

Year Founded1998

Employees1001 - 5000

Annual Revenue$500M - $1B

GW Pharmaceuticals

GW Pharmaceuticals (including company regionals)

gwpharm.com

See more website traffic and engagement information

GW Pharmaceuticals Revenue up to June 2026 is 500M - 1B

revenue generated by GW Pharmaceuticals top domains

GW Pharmaceuticals top domains revenue over 3 years

Revenue for GW Pharmaceuticals top domains

gwpharm.com500M - 1B

See more with Sales Intelligence

Total visits to GW Pharmaceuticals's top domains

Understand GW Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in GW Pharmaceuticals's top domains

Analyze GW Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on GW Pharmaceuticals's top domains

See how GW Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

GW Pharmaceuticals top competitors by domain

Top similar sites in June 2026, ranked by their affinity

astellas.comCompany NameAstellas PharmaEmployees> 10001HQJapan, tokyoAnnual revenue> $1BTotal visits156.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by GW Pharmaceuticals

These are the website technologies, by industry, used by GW Pharmaceuticals top domains

Content Management System (4)

WordPress

Widget (4)

reCAPTCHA

Payment & Currencies (3)

Euro

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from GW Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGwpharm launched CBD-based Epidiolex on Jan 1st '13.GW Pharmaceuticals, which was bought by Irish firm Jazz Pharmaceuticals for $7.2bn in 2021, launched its CBD-based drug Epidiolex in 2018 (it’s known as Epidyolex In Europe).

NewsJazzCares acquired Gwpharm on Nov 9th '22.The pharmaceutical giant Jazz Pharmaceuticals, which recently acquired GW Pharmaceuticals, has been developing a CBDV medication under the code name GPW42006 for several years.

NewsGwpharm had issues with alleged violations of Securities & Exchange Act on Apr 4th '22.On Monday, shareholders Kurt Ziegler and Daniel Brady filed a first amended class action complaint in the Southern District of California against GW Pharmaceuticals, PLC and their executives for alleged violations of Securities & Exchange Act for publishing an allegedly misleading proxy statement that led to an unfavorable merger for the shareholders of GW.